Cargando…
Zonnic®: a new player in an old field
The tobacco industry is continually evolving to adapt to increasing tobacco control pressure and regulation, and to cater to consumer preferences. Recently, RJ Reynolds rolled-out a nicotine-containing gum, Zonnic®, which is marketed as a smoking cessation and reduction product and is sold at conven...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585924/ https://www.ncbi.nlm.nih.gov/pubmed/28877727 http://dx.doi.org/10.1186/s13011-017-0124-3 |
_version_ | 1783261717597257728 |
---|---|
author | Gong, Min Dunbar, Michael S. Setodji, Claude Shadel, William G. |
author_facet | Gong, Min Dunbar, Michael S. Setodji, Claude Shadel, William G. |
author_sort | Gong, Min |
collection | PubMed |
description | The tobacco industry is continually evolving to adapt to increasing tobacco control pressure and regulation, and to cater to consumer preferences. Recently, RJ Reynolds rolled-out a nicotine-containing gum, Zonnic®, which is marketed as a smoking cessation and reduction product and is sold at convenience stores at a lower price and in a smaller quantity than existing brands sold at pharmacies. The introduction of Zonnic® products is a critical first step in tobacco industry’s involvement in the NRT market and a serious indication of the evolving tobacco and nicotine-delivery industry and environment. It is likely that this trend will continue and spread, and as such, have a significant impact at multiple dimensions, including consumer perceptions and behavior, tobacco and NRT industry business strategy, and regulation and policy. In this special communication, we present an overview of the current marketing strategy for Zonnic®, discuss its potential impacts at the market level and at the level of the individual consumer, and suggest research and policy priorities based on the magnitude and urgency of the impacts. |
format | Online Article Text |
id | pubmed-5585924 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-55859242017-09-06 Zonnic®: a new player in an old field Gong, Min Dunbar, Michael S. Setodji, Claude Shadel, William G. Subst Abuse Treat Prev Policy Review The tobacco industry is continually evolving to adapt to increasing tobacco control pressure and regulation, and to cater to consumer preferences. Recently, RJ Reynolds rolled-out a nicotine-containing gum, Zonnic®, which is marketed as a smoking cessation and reduction product and is sold at convenience stores at a lower price and in a smaller quantity than existing brands sold at pharmacies. The introduction of Zonnic® products is a critical first step in tobacco industry’s involvement in the NRT market and a serious indication of the evolving tobacco and nicotine-delivery industry and environment. It is likely that this trend will continue and spread, and as such, have a significant impact at multiple dimensions, including consumer perceptions and behavior, tobacco and NRT industry business strategy, and regulation and policy. In this special communication, we present an overview of the current marketing strategy for Zonnic®, discuss its potential impacts at the market level and at the level of the individual consumer, and suggest research and policy priorities based on the magnitude and urgency of the impacts. BioMed Central 2017-09-06 /pmc/articles/PMC5585924/ /pubmed/28877727 http://dx.doi.org/10.1186/s13011-017-0124-3 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Gong, Min Dunbar, Michael S. Setodji, Claude Shadel, William G. Zonnic®: a new player in an old field |
title | Zonnic®: a new player in an old field |
title_full | Zonnic®: a new player in an old field |
title_fullStr | Zonnic®: a new player in an old field |
title_full_unstemmed | Zonnic®: a new player in an old field |
title_short | Zonnic®: a new player in an old field |
title_sort | zonnic®: a new player in an old field |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585924/ https://www.ncbi.nlm.nih.gov/pubmed/28877727 http://dx.doi.org/10.1186/s13011-017-0124-3 |
work_keys_str_mv | AT gongmin zonnicanewplayerinanoldfield AT dunbarmichaels zonnicanewplayerinanoldfield AT setodjiclaude zonnicanewplayerinanoldfield AT shadelwilliamg zonnicanewplayerinanoldfield |